{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:51:29Z","timestamp":1793285489076,"version":"4.5.0"},"reference-count":181,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T00:00:00Z","timestamp":1668988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T00:00:00Z","timestamp":1668988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s11064-022-03817-4","type":"journal-article","created":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T00:03:07Z","timestamp":1668988987000},"page":"745-766","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":97,"title":["A Potential Link Between Visceral Obesity and Risk of Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"48","author":[{"given":"Hayder M.","family":"Al-Kuraishy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali I.","family":"Al-Gareeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6948-4582","authenticated-orcid":false,"given":"Abdulrahman A.","family":"Alsayegh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7311-2140","authenticated-orcid":false,"given":"Zaki H.","family":"Hakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5297-2678","authenticated-orcid":false,"given":"Nizar A.","family":"Khamjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hebatallah M.","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaber El-Saber","family":"Batiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"De Waard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,21]]},"reference":[{"key":"3817_CR1","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.3390\/brainsci12101290","volume":"12","author":"N Alsubaie","year":"2022","unstructured":"Alsubaie N, Al-kuraishy HM, Al-Gareeb AI, Alharbi B, De Waard M, Sabatier J-M, Saad HM, Batiha GE-S (2022) Statins use in Alzheimer disease: bane or boon from frantic search and narrative review. Brain Sci 12:1290","journal-title":"Brain Sci"},{"key":"3817_CR2","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000512","author":"C Reitz","year":"2020","unstructured":"Reitz C, Rogaeva E, Beecham GW (2020) Late-onset vs nonmendelian early-onset Alzheimer disease: a distinction without a difference? Neurol Genet. https:\/\/doi.org\/10.1212\/NXG.0000000000000512","journal-title":"Neurol Genet"},{"key":"3817_CR3","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1212\/WNL.0000000000007583","volume":"92","author":"DS Knopman","year":"2019","unstructured":"Knopman DS, Petersen RC, Jack CR (2019) A brief history of \u201cAlzheimer disease\u201d: multiple meanings separated by a common name. Neurology 92:1053\u20131059","journal-title":"Neurology"},{"key":"3817_CR4","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","volume":"87","author":"CR Jack","year":"2016","unstructured":"Jack CR, Bennett DA, Blennow K, Carrillo MC, Feldman HH, Frisoni GB, Hampel H, Jagust WJ, Johnson KA, Knopman DS (2016) A\/T\/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology 87:539\u2013547","journal-title":"Neurology"},{"key":"3817_CR5","doi-asserted-by":"publisher","first-page":"e1682","DOI":"10.1212\/WNL.0000000000005476","volume":"90","author":"S Kern","year":"2018","unstructured":"Kern S, Zetterberg H, Kern J, Zettergren A, Waern M, H\u00f6glund K, Andreasson U, Wetterberg H, B\u00f6rjesson-Hanson A, Blennow K (2018) Prevalence of preclinical Alzheimer disease: comparison of current classification systems. Neurology 90:e1682\u2013e1691","journal-title":"Neurology"},{"key":"3817_CR6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2147\/ciia.2006.1.2.143","volume":"1","author":"CW Zhu","year":"2006","unstructured":"Zhu CW, Sano M (2006) Economic considerations in the management of Alzheimer\u2019s disease. Clin Interv Aging 1:143","journal-title":"Clin Interv Aging"},{"key":"3817_CR7","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.bcp.2013.12.024","volume":"88","author":"C Reitz","year":"2014","unstructured":"Reitz C, Mayeux R (2014) Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem Pharmacol 88:640\u2013651","journal-title":"Biochem Pharmacol"},{"key":"3817_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41583-019-0240-3","volume":"21","author":"R van der Kant","year":"2020","unstructured":"van der Kant R, Goldstein LS, Ossenkoppele R (2020) Amyloid-\u03b2-independent regulators of tau pathology in Alzheimer disease. Nat Rev Neurosci 21:21\u201335","journal-title":"Nat Rev Neurosci"},{"key":"3817_CR9","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long JM, Holtzman DM (2019) Alzheimer disease: an update on pathobiology and treatment strategies. Cell 179:312\u2013339","journal-title":"Cell"},{"key":"3817_CR10","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4103\/bc.bc_42_19","volume":"6","author":"HM Al-Kuraishy","year":"2020","unstructured":"Al-Kuraishy HM, Abdulhadi MH, Hussien NR, Al-Niemi MS, Rasheed HA, Al-Gareeb AI (2020) Involvement of orexinergic system in psychiatric and neurodegenerative disorders: a scoping review. Brain Circ 6:70","journal-title":"Brain Circ"},{"key":"3817_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.5455\/jice.20151123043202","volume":"5","author":"HM Al-Kuraishy","year":"2016","unstructured":"Al-Kuraishy HM (2016) Central additive effect of Ginkgo biloba and Rhodiola rosea on psychomotor vigilance task and short-term working memory accuracy. J Intercult Ethnopharmacol 5:7","journal-title":"J Intercult Ethnopharmacol"},{"key":"3817_CR12","first-page":"423","volume":"11","author":"HM Al-Kuraishy","year":"2020","unstructured":"Al-Kuraishy HM, Al-Gareeb AI (2020) Citicoline improves human vigilance and visual working memory: the role of neuronal activation and oxidative stress. Basic Clin Neurosci 11:423","journal-title":"Basic Clin Neurosci"},{"key":"3817_CR13","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00401-019-02036-6","volume":"138","author":"C Petersen","year":"2019","unstructured":"Petersen C, Nolan AL, de Paula Fran\u00e7a Resende E, Miller Z, Ehrenberg AJ, Gorno-Tempini ML, Rosen HJ, Kramer JH, Spina S, Rabinovici GD (2019) Alzheimer\u2019s disease clinical variants show distinct regional patterns of neurofibrillary tangle accumulation. Acta Neuropathol 138:597\u2013612","journal-title":"Acta Neuropathol"},{"key":"3817_CR14","first-page":"34","volume":"25","author":"MF Mendez","year":"2019","unstructured":"Mendez MF (2019) Early-onset Alzheimer disease and its variants. Continuum 25:34","journal-title":"Continuum"},{"key":"3817_CR15","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.3389\/fphar.2018.01247","volume":"9","author":"A Sharma","year":"2018","unstructured":"Sharma A, Pachauri V, Flora S (2018) Advances in multi-functional ligands and the need for metal-related pharmacology for the management of Alzheimer disease. Front Pharmacol 9:1247","journal-title":"Front Pharmacol"},{"key":"3817_CR16","doi-asserted-by":"publisher","first-page":"117957352090739","DOI":"10.1177\/1179573520907397","volume":"12","author":"KG Yiannopoulou","year":"2020","unstructured":"Yiannopoulou KG, Papageorgiou SG (2020) Current and future treatments in Alzheimer disease: an update. J Cent Nerv Syst Dis 12:1179573520907397","journal-title":"J Cent Nerv Syst Dis"},{"key":"3817_CR17","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1038\/oby.2012.19","volume":"20","author":"KL Hildreth","year":"2012","unstructured":"Hildreth KL, Van Pelt RE, Schwartz RS (2012) Obesity, insulin resistance, and Alzheimer\u2019s disease. Obesity 20:1549","journal-title":"Obesity"},{"key":"3817_CR18","doi-asserted-by":"publisher","first-page":"105828","DOI":"10.1155\/2015\/105828","volume":"2015","author":"G Verdile","year":"2015","unstructured":"Verdile G, Keane KN, Cruzat VF, Medic S, Sabale M, Rowles J, Wijesekara N, Martins RN, Fraser PE, Newsholme P (2015) Inflammation and oxidative stress: the molecular connectivity between insulin resistance, obesity, and Alzheimer\u2019s disease. Mediat Inflamm 2015:105828. https:\/\/doi.org\/10.1155\/2015\/105828","journal-title":"Mediat Inflamm"},{"key":"3817_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/WAD.0b013e318222f0d4","volume":"26","author":"JA Luchsinger","year":"2012","unstructured":"Luchsinger JA, Cheng D, Tang MX, Schupf N, Mayeux R (2012) Central obesity in the elderly is related to late onset Alzheimer\u2019s disease. Alzheimer Dis Assoc Disord 26:101","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"3817_CR20","doi-asserted-by":"publisher","first-page":"730827","DOI":"10.1155\/2014\/730827","volume":"2014","author":"MC Amato","year":"2014","unstructured":"Amato MC, Giordano C (2014) Visceral adiposity index: an indicator of adipose tissue dysfunction. Int J Endocrinol 2014:730827. https:\/\/doi.org\/10.1155\/2014\/730827","journal-title":"Int J Endocrinol"},{"key":"3817_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/diseases6010009","volume":"6","author":"HM Al-Kuraishy","year":"2018","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Al-Buhadilly AK (2018) Rosuvastatin improves vaspin serum levels in obese patients with acute coronary syndrome. Diseases 6:9","journal-title":"Diseases"},{"key":"3817_CR22","doi-asserted-by":"publisher","first-page":"408","DOI":"10.5455\/jice.20160815080732","volume":"5","author":"HM Al-Kuraishy","year":"2016","unstructured":"Al-Kuraishy HM, Al-Gareeb AI (2016) Effect of orlistat alone or in combination with Garcinia cambogia on visceral adiposity index in obese patients. J Intercult Ethnopharmacol 5:408","journal-title":"J Intercult Ethnopharmacol"},{"key":"3817_CR23","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.3390\/ph15091147","volume":"15","author":"BM Alomair","year":"2022","unstructured":"Alomair BM, Al-kuraishy HM, Al-Gareeb AI, Al-Hamash SM, De Waard M, Sabatier J-M, Saad HM, El-Saber Batiha G (2022) Montelukast and acute coronary syndrome: the endowed drug. Pharmaceuticals 15:1147","journal-title":"Pharmaceuticals"},{"key":"3817_CR24","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/ajcn\/72.3.694","volume":"72","author":"D Gallagher","year":"2000","unstructured":"Gallagher D, Heymsfield SB, Heo M, Jebb SA, Murgatroyd PR, Sakamoto Y (2000) Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr 72:694\u2013701","journal-title":"Am J Clin Nutr"},{"key":"3817_CR25","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1542\/peds.2008-3586E","volume":"124","author":"DS Freedman","year":"2009","unstructured":"Freedman DS, Sherry B (2009) The validity of BMI as an indicator of body fatness and risk among children. Pediatrics 124:S23\u2013S34","journal-title":"Pediatrics"},{"key":"3817_CR26","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1001\/jama.293.15.1861","volume":"293","author":"KM Flegal","year":"2005","unstructured":"Flegal KM, Graubard BI, Williamson DF, Gail MH (2005) Excess deaths associated with underweight, overweight, and obesity. JAMA 293:1861\u20131867","journal-title":"JAMA"},{"key":"3817_CR27","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/S0140-6736(06)69251-9","volume":"368","author":"A Romero-Corral","year":"2006","unstructured":"Romero-Corral A, Montori VM, Somers VK, Korinek J, Thomas RJ, Allison TG, Mookadam F, Lopez-Jimenez F (2006) Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 368:666\u2013678","journal-title":"Lancet"},{"key":"3817_CR28","doi-asserted-by":"publisher","first-page":"416","DOI":"10.20945\/2359-3997000000055","volume":"62","author":"CPS Pinho","year":"2018","unstructured":"Pinho CPS, Diniz AdS, Arruda IKGd, Leite APDL, Petribu MdMV, Rodrigues IG (2018) Waist circumference measurement sites and their association with visceral and subcutaneous fat and cardiometabolic abnormalities. Arch Endocrinol Metab 62:416\u2013423","journal-title":"Arch Endocrinol Metab"},{"key":"3817_CR29","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.numecd.2017.06.015","volume":"27","author":"G-M Kouli","year":"2017","unstructured":"Kouli G-M, Panagiotakos DB, Kyrou I, Georgousopoulou EN, Chrysohoou C, Tsigos C, Tousoulis D, Pitsavos C (2017) Visceral adiposity index and 10-year cardiovascular disease incidence: the ATTICA study. Nutr Metab Cardiovasc Dis 27:881\u2013889","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"3817_CR30","doi-asserted-by":"publisher","first-page":"920","DOI":"10.2337\/dc09-1825","volume":"33","author":"MC Amato","year":"2010","unstructured":"Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, Galluzzo A, Group AS (2010) Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care 33:920\u2013922","journal-title":"Diabetes Care"},{"key":"3817_CR31","doi-asserted-by":"publisher","first-page":"111019","DOI":"10.1016\/j.exger.2020.111019","volume":"139","author":"B Li","year":"2020","unstructured":"Li B, Lai X, Yan C, Jia X, Li Y (2020) The associations between neutrophil-to-lymphocyte ratio and the Chinese visceral adiposity index, and carotid atherosclerosis and atherosclerotic cardiovascular disease risk. Exp Gerontol 139:111019","journal-title":"Exp Gerontol"},{"key":"3817_CR32","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.numecd.2021.10.020","volume":"32","author":"Y Xie","year":"2022","unstructured":"Xie Y, Zhang Y, Qin P, Ping Z, Wang C, Peng X, Chen H, Zhao D, Xu S, Wang L (2022) The association between Chinese Visceral Adipose Index and coronary heart disease: a cohort study in China. Nutr Metab Cardiovasc Dis 32:550\u2013559","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"3817_CR33","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.dsx.2019.01.056","volume":"13","author":"R Nusrianto","year":"2019","unstructured":"Nusrianto R, Tahapary DL, Soewondo P (2019) Visceral adiposity index as a predictor for type 2 diabetes mellitus in Asian population: a systematic review. Diabetes Metab Syndr: Clin Res Rev 13:1231\u20131235","journal-title":"Diabetes Metab Syndr: Clin Res Rev"},{"key":"3817_CR34","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1089\/met.2019.0005","volume":"17","author":"S Pekgor","year":"2019","unstructured":"Pekgor S, Duran C, Berberoglu U, Eryilmaz MA (2019) The role of visceral adiposity index levels in predicting the presence of metabolic syndrome and insulin resistance in overweight and obese patients. Metab Syndr Relat Disord 17:296\u2013302","journal-title":"Metab Syndr Relat Disord"},{"key":"3817_CR35","doi-asserted-by":"publisher","first-page":"107798","DOI":"10.1016\/j.diabres.2019.107798","volume":"155","author":"R Nusrianto","year":"2019","unstructured":"Nusrianto R, Ayundini G, Kristanti M, Astrella C, Amalina N, Riyadina W, Tahapary DL, Soewondo P (2019) Visceral adiposity index and lipid accumulation product as a predictor of type 2 diabetes mellitus: the Bogor cohort study of non-communicable diseases risk factors. Diabetes Res Clin Pract 155:107798","journal-title":"Diabetes Res Clin Pract"},{"key":"3817_CR36","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s11739-018-1849-3","volume":"13","author":"TV Fiorentino","year":"2018","unstructured":"Fiorentino TV (2018) Visceral adiposity index (VAI), a powerful predictor of incident hypertension in prehypertensives. Intern Emerg Med 13:471\u2013473","journal-title":"Intern Emerg Med"},{"key":"3817_CR37","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1139\/apnm-2012-0307","volume":"38","author":"B Elisha","year":"2013","unstructured":"Elisha B, Messier V, Karelis A, Coderre L, Bernard S, Prud\u2019homme D, Rabasa-Lhoret R (2013) The visceral adiposity index: relationship with cardiometabolic risk factors in obese and overweight postmenopausal women\u2014a MONET group study. Appl Physiol Nutr Metab 38:892\u2013899","journal-title":"Appl Physiol Nutr Metab"},{"issue":"3","key":"3817_CR38","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s40268-022-00397-0","volume":"22","author":"L Alkazmi","year":"2022","unstructured":"Alkazmi L, Al-kuraishy HM, Batiha GE-S, Mostafa-Hedeab G, De Waard M, Sabatier J-M, Kabrah SM, Saad HM, Al-Gareeb AI, Simal-Gandara J (2022) Roxadustat for SARS-CoV-2 infection: old signaling raised new hopes. Drugs R&D 22(3):183\u2013186","journal-title":"Drugs R&D"},{"key":"3817_CR39","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.physbeh.2018.02.044","volume":"190","author":"AM Magnuson","year":"2018","unstructured":"Magnuson AM, Fouts JK, Regan DP, Booth AD, Dow SW, Foster MT (2018) Adipose tissue extrinsic factor: obesity-induced inflammation and the role of the visceral lymph node. Physiol Behav 190:71\u201381","journal-title":"Physiol Behav"},{"key":"3817_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-022-01027-6","author":"HM Al-kuraishy","year":"2022","unstructured":"Al-kuraishy HM, Batiha GE-S, Faidah H, Al-Gareeb AI, Saad HM, Simal-Gandara J (2022) Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals. Inflammopharmacology. https:\/\/doi.org\/10.1007\/s10787-022-01027-6","journal-title":"Inflammopharmacology"},{"key":"3817_CR41","doi-asserted-by":"publisher","first-page":"463850","DOI":"10.1155\/2012\/463850","volume":"2012","author":"KE Rhee","year":"2012","unstructured":"Rhee KE, Phelan S, McCaffery J (2012) Early determinants of obesity: genetic, epigenetic, and in utero influences. Int J Pediatr 2012:463850. https:\/\/doi.org\/10.1155\/2012\/463850","journal-title":"Int J Pediatr"},{"key":"3817_CR42","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13098-022-00900-2","volume":"14","author":"GE-S Batiha","year":"2022","unstructured":"Batiha GE-S, Al-kuraishy HM, Al-Maiahy TJ, Al-Buhadily AK, Saad HM, Al-Gareeb AI, Simal-Gandara J (2022) Plasminogen activator inhibitor 1 and gestational diabetes: the causal relationship. Diabetol Metab Syndr 14:127","journal-title":"Diabetol Metab Syndr"},{"key":"3817_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13148-016-0301-7","volume":"9","author":"T Nevalainen","year":"2017","unstructured":"Nevalainen T, Kananen L, Marttila S, Jylh\u00e4v\u00e4 J, Mononen N, K\u00e4h\u00f6nen M, Raitakari OT, Hervonen A, Jylh\u00e4 M, Lehtim\u00e4ki T (2017) Obesity accelerates epigenetic aging in middle-aged but not in elderly individuals. Clin Epigenetics 9:1\u20139","journal-title":"Clin Epigenetics"},{"key":"3817_CR44","doi-asserted-by":"publisher","first-page":"7847","DOI":"10.1002\/jcp.27847","volume":"234","author":"XH Ou","year":"2019","unstructured":"Ou XH, Zhu CC, Sun SC (2019) Effects of obesity and diabetes on the epigenetic modification of mammalian gametes. J Cell Physiol 234:7847\u20137855","journal-title":"J Cell Physiol"},{"key":"3817_CR45","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/proteomes4020014","volume":"4","author":"IJ Martins","year":"2016","unstructured":"Martins IJ (2016) The role of clinical proteomics, lipidomics, and genomics in the diagnosis of Alzheimer\u2019s disease. Proteomes 4:14","journal-title":"Proteomes"},{"key":"3817_CR46","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3389\/fendo.2020.00267","volume":"11","author":"S Khan","year":"2020","unstructured":"Khan S, Chan YT, Revelo XS, Winer DA (2020) The immune landscape of visceral adipose tissue during obesity and aging. Front Endocrinol 11:267","journal-title":"Front Endocrinol"},{"key":"3817_CR47","doi-asserted-by":"publisher","first-page":"e14740","DOI":"10.1097\/MD.0000000000014740","volume":"98","author":"J-Y Yu","year":"2019","unstructured":"Yu J-Y, Choi W-J, Lee H-S, Lee J-W (2019) Relationship between inflammatory markers and visceral obesity in obese and overweight Korean adults: an observational study. Medicine 98:e14740","journal-title":"Medicine"},{"key":"3817_CR48","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-022-00987-z","author":"G El-Saber Batiha","year":"2022","unstructured":"El-Saber Batiha G, Al-Gareeb AI, Saad HM, Al-Kuraishy HM (2022) COVID-19 and corticosteroids: a narrative review. Inflammopharmacology. https:\/\/doi.org\/10.1007\/s10787-022-00987-z","journal-title":"Inflammopharmacology"},{"key":"3817_CR49","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1126\/science.7678183","volume":"259","author":"GS Hotamisligil","year":"1993","unstructured":"Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-\u03b1: direct role in obesity-linked insulin resistance. Science 259:87\u201391","journal-title":"Science"},{"key":"3817_CR50","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1007\/s10753-014-9914-1","volume":"37","author":"G Ghigliotti","year":"2014","unstructured":"Ghigliotti G, Barisione C, Garibaldi S, Fabbi P, Brunelli C, Spallarossa P, Altieri P, Rosa G, Spinella G, Palombo D (2014) Adipose tissue immune response: novel triggers and consequences for chronic inflammatory conditions. Inflammation 37:1337\u20131353","journal-title":"Inflammation"},{"key":"3817_CR51","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-022-00993-1","author":"G Mostafa-Hedeab","year":"2022","unstructured":"Mostafa-Hedeab G, Al-Kuraishy HM, Al-Gareeb AI, Jeandet P, Saad HM, Batiha GE-S (2022) A raising dawn of pentoxifylline in management of inflammatory disorders in Covid-19. Inflammopharmacology. https:\/\/doi.org\/10.1007\/s10787-022-00993-1","journal-title":"Inflammopharmacology"},{"key":"3817_CR52","first-page":"504","volume":"11","author":"RJ Henning","year":"2021","unstructured":"Henning RJ (2021) Obesity and obesity-induced inflammatory disease contribute to atherosclerosis: a review of the pathophysiology and treatment of obesity. Am J Cardiovasc Dis 11:504","journal-title":"Am J Cardiovasc Dis"},{"key":"3817_CR53","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1080\/08830185.2019.1638921","volume":"38","author":"M Singh","year":"2019","unstructured":"Singh M, Benencia F (2019) Inflammatory processes in obesity: focus on endothelial dysfunction and the role of adipokines as inflammatory mediators: we reviewed obesity-induced metabolic and immunological changes at the level of vasculature and emphasize on the importance of adipokines. Int Rev Immunol 38:157\u2013171","journal-title":"Int Rev Immunol"},{"key":"3817_CR54","doi-asserted-by":"publisher","first-page":"113225","DOI":"10.1016\/j.biopha.2022.113225","volume":"152","author":"M Alorabi","year":"2022","unstructured":"Alorabi M, Cavalu S, Al-Kuraishy HM, Al-Gareeb AI, Mostafa-Hedeab G, Negm WA, Youssef A, El-Kadem AH, Saad HM, Batiha GE-S (2022) Pentoxifylline and berberine mitigate diclofenac-induced acute nephrotoxicity in male rats via modulation of inflammation and oxidative stress. Biomed Pharmacother 152:113225","journal-title":"Biomed Pharmacother"},{"key":"3817_CR55","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.3390\/ijms22094798","volume":"22","author":"G Battineni","year":"2021","unstructured":"Battineni G, Sagaro GG, Chintalapudi N, Amenta F, Tomassoni D, Tayebati SK (2021) Impact of obesity-induced inflammation on cardiovascular diseases (CVD). Int J Mol Sci 22:4798","journal-title":"Int J Mol Sci"},{"key":"3817_CR56","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.3390\/diagnostics12092051","volume":"12","author":"AO Babalghith","year":"2022","unstructured":"Babalghith AO, Al-kuraishy HM, Al-Gareeb AI, De Waard M, Sabatier J-M, Saad HM, Batiha GE-S (2022) The potential role of growth differentiation factor 15 in COVID-19: a corollary subjective effect or not? Diagnostics 12:2051","journal-title":"Diagnostics"},{"key":"3817_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jksus.2022.102347","author":"HM Al-Kuraishy","year":"2022","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Bungau SG, Radu A-F, Batiha GE-S (2022) The potential molecular implications of adiponectin in the evolution of SARS-CoV-2: inbuilt tendency. J King Saud Univ Sci. https:\/\/doi.org\/10.1016\/j.jksus.2022.102347","journal-title":"J King Saud Univ Sci"},{"key":"3817_CR58","first-page":"S17","volume":"71","author":"MH Abdulhadi","year":"2021","unstructured":"Abdulhadi MH, Al-Kuraishy HM, Al-Gareeb AI (2021) Beneficial effects of levothyroxine replacement therapy on leptin adiponectin ratio in patients with idiopathic primary hypothyroidism. J Pak Med Assoc 71:S17\u201321","journal-title":"J Pak Med Assoc"},{"key":"3817_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12902-019-0386-z","volume":"19","author":"S Gariballa","year":"2019","unstructured":"Gariballa S, Alkaabi J, Yasin J, Al Essa A (2019) Total adiponectin in overweight and obese subjects and its response to visceral fat loss. BMC Endocr Disord 19:1\u20136","journal-title":"BMC Endocr Disord"},{"key":"3817_CR60","doi-asserted-by":"publisher","first-page":"474","DOI":"10.2337\/db16-0933","volume":"66","author":"Y Hurtado-Roca","year":"2017","unstructured":"Hurtado-Roca Y, Bueno H, Fernandez-Ortiz A, Ordovas JM, Iba\u00f1ez B, Fuster V, Rodriguez-Artalejo F, Laclaustra M (2017) Oxidized LDL is associated with metabolic syndrome traits independently of central obesity and insulin resistance. Diabetes 66:474\u2013482","journal-title":"Diabetes"},{"key":"3817_CR61","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/ijpvm.IJPVM_278_19","volume":"12","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Hussian NR, Al-Naimi MS, Al-Gareeb AI, Al-Mamorri F, Al-Buhadily AK (2021) The potential role of pancreatic \u03b3-aminobutyric acid (GABA) in diabetes mellitus: a critical reappraisal. Int J Prev Med 12:19","journal-title":"Int J Prev Med"},{"key":"3817_CR62","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4103\/japtr.JAPTR_273_18","volume":"9","author":"HM Al-Kuraishy","year":"2018","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Waheed HJ, Al-Maiahy TJ (2018) Differential effect of metformin and\/or glyburide on apelin serum levels in patients with type 2 diabetes mellitus: concepts and clinical practice. J Adv Pharm Technol Res 9:80","journal-title":"J Adv Pharm Technol Res"},{"key":"3817_CR63","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.clon.2010.02.001","volume":"22","author":"L Healy","year":"2010","unstructured":"Healy L, Ryan A, Carroll P, Ennis D, Crowley V, Boyle T, Kennedy M, Connolly E, Reynolds J (2010) Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer. Clin Oncol 22:281\u2013288","journal-title":"Clin Oncol"},{"key":"3817_CR64","doi-asserted-by":"publisher","first-page":"317","DOI":"10.4103\/JLP.JLP_123_19","volume":"11","author":"HM Al-Kuraishy","year":"2019","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Shams HA, Al-Mamorri F (2019) Endothelial dysfunction and inflammatory biomarkers as a response factor of concurrent coenzyme Q10 add-on metformin in patients with type 2 diabetes mellitus. J Lab Physicians 11:317\u2013322","journal-title":"J Lab Physicians"},{"key":"3817_CR65","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4103\/japtr.JAPTR_65_19","volume":"10","author":"HA Rasheed","year":"2019","unstructured":"Rasheed HA, Al-Kuraishy HM, Al-Gareeb AI, Hussien NR, Al-Nami MS (2019) Effects of diabetic pharmacotherapy on prolactin hormone in patients with type 2 diabetes mellitus: bane or boon. J Adv Pharm Technol Res 10:163","journal-title":"J Adv Pharm Technol Res"},{"key":"3817_CR66","doi-asserted-by":"publisher","first-page":"874","DOI":"10.3390\/ijms20040874","volume":"20","author":"M Maciejczyk","year":"2019","unstructured":"Maciejczyk M, \u017bebrowska E, Chabowski A (2019) Insulin resistance and oxidative stress in the brain: what\u2019s new? Int J Mol Sci 20:874","journal-title":"Int J Mol Sci"},{"issue":"Suppl 3","key":"3817_CR67","first-page":"S88","volume":"69","author":"MS Al-Naimi","year":"2019","unstructured":"Al-Naimi MS, Rasheed HA, Al-Kuraishy HM, Al-Gareeb AI (2019) Berberine attenuates olanzapine induced-metabolic syndrome. J Pak Med Assoc 69(Suppl 3):S88\u2013s92","journal-title":"J Pak Med Assoc"},{"key":"3817_CR68","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11684-013-0262-6","volume":"7","author":"J Ye","year":"2013","unstructured":"Ye J (2013) Mechanisms of insulin resistance in obesity. Front Med 7:14\u201324","journal-title":"Front Med"},{"key":"3817_CR69","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/MED.0b013e3283514e13","volume":"19","author":"OT Hardy","year":"2012","unstructured":"Hardy OT, Czech MP, Corvera S (2012) What causes the insulin resistance underlying obesity? Curr Opin Endocrinol Diabetes Obes 19:81","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"3817_CR70","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.clindermatol.2004.01.011","volume":"22","author":"JR Greenfield","year":"2004","unstructured":"Greenfield JR, Campbell LV (2004) Insulin resistance and obesity. Clin Dermatol 22:289\u2013295","journal-title":"Clin Dermatol"},{"key":"3817_CR71","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1177\/153537020322801003","volume":"228","author":"T Kadowaki","year":"2003","unstructured":"Kadowaki T, Hara K, Yamauchi T, Terauchi Y, Tobe K, Nagai R (2003) Molecular mechanism of insulin resistance and obesity. Exp Biol Med 228:1111\u20131117","journal-title":"Exp Biol Med"},{"key":"3817_CR72","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4103\/IJCIIS.IJCIIS_62_19","volume":"10","author":"MS Al-Nami","year":"2020","unstructured":"Al-Nami MS, Al-Kuraishy HM, Al-Gareeb AI (2020) Impact of thioctic acid on glycemic indices and associated inflammatory-induced endothelial dysfunction in patients with type 2 diabetes mellitus: a case control study. Int J Crit Illn Inj Sci 10:21","journal-title":"Int J Crit Illn Inj Sci"},{"key":"3817_CR73","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1161\/CIRCRESAHA.119.315896","volume":"126","author":"H Wu","year":"2020","unstructured":"Wu H, Ballantyne CM (2020) Metabolic inflammation and insulin resistance in obesity. Circ Res 126:1549\u20131564","journal-title":"Circ Res"},{"key":"3817_CR74","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/ana.25826","volume":"88","author":"Z Arvanitakis","year":"2020","unstructured":"Arvanitakis Z, Wang HY, Capuano AW, Khan A, Ta\u00efb B, Anokye-Danso F, Schneider JA, Bennett DA, Ahima RS, Arnold SE (2020) Brain insulin signaling, Alzheimer disease pathology, and cognitive function. Ann Neurol 88:513\u2013525","journal-title":"Ann Neurol"},{"key":"3817_CR75","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s12035-019-01827-y","volume":"57","author":"MC Selles","year":"2020","unstructured":"Selles MC, Fortuna JT, Zappa-Villar MF, de Faria YP, Souza AS, Suemoto CK, Leite RE, Rodriguez RD, Grinberg LT, Reggiani PC (2020) Adenovirus-mediated transduction of insulin-like growth factor 1 protects hippocampal neurons from the toxicity of A\u03b2 oligomers and prevents memory loss in an Alzheimer mouse model. Mol Neurobiol 57:1473\u20131483","journal-title":"Mol Neurobiol"},{"key":"3817_CR76","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s40263-020-00781-x","volume":"35","author":"M Hallschmid","year":"2021","unstructured":"Hallschmid M (2021) Intranasal insulin for Alzheimer\u2019s disease. CNS Drugs 35:21\u201337","journal-title":"CNS Drugs"},{"key":"3817_CR77","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/cns.12866","volume":"24","author":"I Pomytkin","year":"2018","unstructured":"Pomytkin I, Costa-Nunes JP, Kasatkin V, Veniaminova E, Demchenko A, Lyundup A, Lesch KP, Ponomarev ED, Strekalova T (2018) Insulin receptor in the brain: mechanisms of activation and the role in the CNS pathology and treatment. CNS Neurosci Ther 24:763\u2013774","journal-title":"CNS Neurosci Ther"},{"key":"3817_CR78","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/emmm.201100177","volume":"3","author":"T Kuwabara","year":"2011","unstructured":"Kuwabara T, Kagalwala MN, Onuma Y, Ito Y, Warashina M, Terashima K, Sanosaka T, Nakashima K, Gage FH, Asashima M (2011) Insulin biosynthesis in neuronal progenitors derived from adult hippocampus and the olfactory bulb. EMBO Mol Med 3:742\u2013754","journal-title":"EMBO Mol Med"},{"key":"3817_CR79","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.neurobiolaging.2005.09.018","volume":"26","author":"A Convit","year":"2005","unstructured":"Convit A (2005) Links between cognitive impairment in insulin resistance: an explanatory model. Neurobiol Aging 26:31\u201335","journal-title":"Neurobiol Aging"},{"key":"3817_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1023\/A:1022598900246","volume":"23","author":"K Gerozissis","year":"2003","unstructured":"Gerozissis K (2003) Brain insulin: regulation, mechanisms of action and functions. Cell Mol Neurobiol 23:1\u201325","journal-title":"Cell Mol Neurobiol"},{"key":"3817_CR81","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.neuropharm.2017.11.037","volume":"136","author":"CD Chapman","year":"2018","unstructured":"Chapman CD, Schi\u00f6th HB, Grillo CA, Benedict C (2018) Intranasal insulin in Alzheimer\u2019s disease: food for thought. Neuropharmacology 136:196\u2013201","journal-title":"Neuropharmacology"},{"key":"3817_CR82","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/S1474-4422(20)30231-3","volume":"19","author":"D Kellar","year":"2020","unstructured":"Kellar D, Craft S (2020) Brain insulin resistance in Alzheimer\u2019s disease and related disorders: mechanisms and therapeutic approaches. Lancet Neurol 19:758\u2013766","journal-title":"Lancet Neurol"},{"key":"3817_CR83","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.bbadis.2016.10.006","volume":"1863","author":"V Kothari","year":"2017","unstructured":"Kothari V, Luo Y, Tornabene T, O\u2019Neill AM, Greene MW, Geetha T, Babu JR (2017) High fat diet induces brain insulin resistance and cognitive impairment in mice. Biochim Biophys Acta 1863:499\u2013508","journal-title":"Biochim Biophys Acta"},{"key":"3817_CR84","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1073\/pnas.0809158106","volume":"106","author":"FG De Felice","year":"2009","unstructured":"De Felice FG, Vieira MN, Bomfim TR, Decker H, Velasco PT, Lambert MP, Viola KL, Zhao W-Q, Ferreira ST, Klein WL (2009) Protection of synapses against Alzheimer\u2019s-linked toxins: insulin signaling prevents the pathogenic binding of A\u03b2 oligomers. Proc Natl Acad Sci USA 106:1971\u20131976","journal-title":"Proc Natl Acad Sci USA"},{"key":"3817_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep46359","volume":"7","author":"M Gratuze","year":"2017","unstructured":"Gratuze M, Julien J, Petry FR, Morin F, Planel E (2017) Insulin deprivation induces PP2A inhibition and tau hyperphosphorylation in hTau mice, a model of Alzheimer\u2019s disease-like tau pathology. Sci Rep 7:1\u201313","journal-title":"Sci Rep"},{"key":"3817_CR86","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.3390\/molecules25245789","volume":"25","author":"Z Breijyeh","year":"2020","unstructured":"Breijyeh Z, Karaman R (2020) Comprehensive review on Alzheimer\u2019s disease: causes and treatment. Molecules 25:5789","journal-title":"Molecules"},{"key":"3817_CR87","doi-asserted-by":"publisher","first-page":"117727192096410","DOI":"10.1177\/1177271920964108","volume":"15","author":"D Bradley","year":"2020","unstructured":"Bradley D (2020) Clusterin as a potential biomarker of obesity-related Alzheimer\u2019s disease risk. Biomark Insights 15:1177271920964108","journal-title":"Biomark Insights"},{"key":"3817_CR88","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/bpa.12660","volume":"29","author":"SB Oh","year":"2019","unstructured":"Oh SB, Kim MS, Park S, Son H, Kim SY, Kim MS, Jo DG, Tak E, Lee JY (2019) Clusterin contributes to early stage of Alzheimer\u2019s disease pathogenesis. Brain Pathol 29:217\u2013231","journal-title":"Brain Pathol"},{"key":"3817_CR89","doi-asserted-by":"publisher","first-page":"612496","DOI":"10.3389\/fimmu.2021.612496","volume":"12","author":"J Wittwer","year":"2021","unstructured":"Wittwer J, Bradley D (2021) Clusterin and its role in insulin resistance and the cardiometabolic syndrome. Front Immunol 12:612496","journal-title":"Front Immunol"},{"key":"3817_CR90","doi-asserted-by":"publisher","first-page":"e0134531","DOI":"10.1371\/journal.pone.0134531","volume":"10","author":"F-S Shie","year":"2015","unstructured":"Shie F-S, Shiao Y-J, Yeh C-W, Lin C-H, Tzeng T-T, Hsu H-C, Huang F-L, Tsay H-J, Liu H-K (2015) Obesity and hepatic steatosis are associated with elevated serum amyloid beta in metabolically stressed APPswe\/PS1dE9 mice. PLoS ONE 10:e0134531","journal-title":"PLoS ONE"},{"key":"3817_CR91","first-page":"4104","volume":"130","author":"PJ Meakin","year":"2020","unstructured":"Meakin PJ, Coull BM, Tuharska Z, McCaffery C, Akoumianakis I, Antoniades C, Brown J, Griffin KJ, Platt F, Ozber CH (2020) Elevated circulating amyloid concentrations in obesity and diabetes promote vascular dysfunction. J Clin Investig 130:4104\u20134117","journal-title":"J Clin Investig"},{"key":"3817_CR92","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.neuroscience.2015.12.011","volume":"315","author":"TL Platt","year":"2016","unstructured":"Platt TL, Beckett TL, Kohler K, Niedowicz DM, Murphy MP (2016) Obesity, diabetes, and leptin resistance promote tau pathology in a mouse model of disease. Neuroscience 315:162\u2013174","journal-title":"Neuroscience"},{"key":"3817_CR93","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1111\/j.1471-4159.2007.04930.x","volume":"103","author":"I Kelleher","year":"2007","unstructured":"Kelleher I, Garwood C, Hanger DP, Anderton BH, Noble W (2007) Kinase activities increase during the development of tauopathy in htau mice. J Neurochem 103:2256\u20132267","journal-title":"J Neurochem"},{"key":"3817_CR94","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3390\/jcm7110407","volume":"7","author":"OY Kim","year":"2018","unstructured":"Kim OY, Song J (2018) The role of irisin in Alzheimer\u2019s disease. J Clin Med 7:407","journal-title":"J Clin Med"},{"key":"3817_CR95","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.3390\/molecules23123229","volume":"23","author":"Y Jin","year":"2018","unstructured":"Jin Y, Sumsuzzman DM, Choi J, Kang H, Lee S-R, Hong Y (2018) Molecular and functional interaction of the myokine irisin with physical exercise and Alzheimer\u2019s disease. Molecules 23:3229","journal-title":"Molecules"},{"key":"3817_CR96","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9470178","author":"DE Rotimi","year":"2022","unstructured":"Rotimi DE, Ben-Goru GM, Evbuomwan IO, Elebiyo TC, Alorabi M, Farasani A, Batiha GE-S, Adeyemi OS (2022) Zingiber officinale and Vernonia amygdalina infusions improve redox status in rat brain. Evid Based Complement Alternat Med. https:\/\/doi.org\/10.1155\/2022\/9470178","journal-title":"Evid Based Complement Alternat Med"},{"key":"3817_CR97","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/jnc.15039","volume":"155","author":"GB de Freitas","year":"2020","unstructured":"de Freitas GB, Lourenco MV, De Felice FG (2020) Protective actions of exercise-related FNDC5\/Irisin in memory and Alzheimer\u2019s disease. J Neurochem 155:602\u2013611","journal-title":"J Neurochem"},{"key":"3817_CR98","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3389\/fendo.2019.00524","volume":"10","author":"LI Arhire","year":"2019","unstructured":"Arhire LI, Mihalache L, Covasa M (2019) Irisin: a hope in understanding and managing obesity and metabolic syndrome. Front Endocrinol 10:524","journal-title":"Front Endocrinol"},{"key":"3817_CR99","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8956509","author":"WK Leung","year":"2018","unstructured":"Leung WK, Yu AP, Lai CW, Siu PM (2018) Association of markers of proinflammatory phenotype and beige adipogenesis with metabolic syndrome in chinese centrally obese adults. J Diabetes Research. https:\/\/doi.org\/10.1155\/2018\/8956509","journal-title":"J Diabetes Research"},{"key":"3817_CR100","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.1532-5415.2007.01458.x","volume":"56","author":"AR Atti","year":"2008","unstructured":"Atti AR, Palmer K, Volpato S, Winblad B, De Ronchi D, Fratiglioni L (2008) Late-life body mass index and dementia incidence: nine\u2010year follow\u2010up data from the Kungsholmen Project. J Am Geriatr Soc 56:111\u2013116","journal-title":"J Am Geriatr Soc"},{"key":"3817_CR101","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ejphar.2008.01.052","volume":"585","author":"D Gustafson","year":"2008","unstructured":"Gustafson D (2008) A life course of adiposity and dementia. Eur J Pharmacol 585:163\u2013175","journal-title":"Eur J Pharmacol"},{"key":"3817_CR102","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1001\/archneurol.2010.38","volume":"67","author":"JM Burns","year":"2010","unstructured":"Burns JM, Johnson DK, Watts A, Swerdlow RH, Brooks WM (2010) Reduced lean mass in early Alzheimer disease and its association with brain atrophy. Arch Neurol 67:428\u2013433","journal-title":"Arch Neurol"},{"key":"3817_CR103","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/WAD.0000000000000079","volume":"29","author":"HJ Kim","year":"2015","unstructured":"Kim HJ, Kim C, Jeon S, Kang M, Kim YJ, Lee J-M, Shin H-Y, Cho H, Ye BS, Kim J-H (2015) Association of body fat percentage and waist-hip ratio with brain cortical thickness. Alzheimer Dis Assoc Disord 29:279\u2013286","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"3817_CR104","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3233\/JAD-2009-1050","volume":"17","author":"KA Bates","year":"2009","unstructured":"Bates KA, Sohrabi HR, Rodrigues M, Beilby J, Dhaliwal SS, Taddei K, Criddle A, Wraith M, Howard M, Martins G (2009) Association of cardiovascular factors and Alzheimer\u2019s disease plasma amyloid-\u03b2 protein in subjective memory complainers. J Alzheimers Dis 17:305\u2013318","journal-title":"J Alzheimers Dis"},{"key":"3817_CR105","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.orcp.2016.04.003","volume":"11","author":"EP Pasha","year":"2017","unstructured":"Pasha EP, Birdsill A, Parker P, Elmenshawy A, Tanaka H, Haley AP (2017) Visceral adiposity predicts subclinical white matter hyperintensities in middle-aged adults. Obes Res Clin Pract 11:177\u2013187","journal-title":"Obes Res Clin Pract"},{"key":"3817_CR106","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.biopha.2018.08.034","volume":"107","author":"HE Mohamed","year":"2018","unstructured":"Mohamed HE, Abo-ELmatty DM, Mesbah NM, Saleh SM, Ali A-MA, Sakr AT (2018) Raspberry ketone preserved cholinergic activity and antioxidant defense in obesity induced Alzheimer disease in rats. Biomed Pharmacother 107:1166\u20131174","journal-title":"Biomed Pharmacother"},{"key":"3817_CR107","doi-asserted-by":"publisher","first-page":"890","DOI":"10.3390\/ph14090890","volume":"14","author":"SR Poor","year":"2021","unstructured":"Poor SR, Ettcheto M, Cano A, Sanchez-Lopez E, Manzine PR, Olloquequi J, Camins A, Javan M (2021) Metformin a potential pharmacological strategy in late onset Alzheimer\u2019s disease treatment. Pharmaceuticals 14:890","journal-title":"Pharmaceuticals"},{"key":"3817_CR108","doi-asserted-by":"publisher","first-page":"101095","DOI":"10.1016\/j.arr.2020.101095","volume":"62","author":"S Ebrahimpour","year":"2020","unstructured":"Ebrahimpour S, Zakeri M, Esmaeili A (2020) Crosstalk between obesity, diabetes, and alzheimer\u2019s disease: Introducing quercetin as an effective triple herbal medicine. Ageing Res Rev 62:101095","journal-title":"Ageing Res Rev"},{"key":"3817_CR109","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.3390\/ijms21041241","volume":"21","author":"F Donohoe","year":"2020","unstructured":"Donohoe F, Wilkinson M, Baxter E, Brennan DJ (2020) Mitogen-activated protein kinase (MAPK) and obesity-related cancer. Int J Mol Sci 21:1241","journal-title":"Int J Mol Sci"},{"key":"3817_CR110","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.neuropharm.2009.11.010","volume":"58","author":"L Munoz","year":"2010","unstructured":"Munoz L, Ammit AJ (2010) Targeting p38 MAPK pathway for the treatment of Alzheimer\u2019s disease. Neuropharmacology 58:561\u2013568","journal-title":"Neuropharmacology"},{"key":"3817_CR111","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1038\/jcbfm.2013.82","volume":"33","author":"A-L Lin","year":"2013","unstructured":"Lin A-L, Zheng W, Halloran JJ, Burbank RR, Hussong SA, Hart MJ, Javors M, Shih Y-YI, Muir E, Fonseca RS (2013) Chronic rapamycin restores brain vascular integrity and function through NO synthase activation and improves memory in symptomatic mice modeling Alzheimer\u2019s disease. J Cereb Blood Flow Metab 33:1412\u20131421","journal-title":"J Cereb Blood Flow Metab"},{"key":"3817_CR112","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nm.2279","volume":"17","author":"B Vandanmagsar","year":"2011","unstructured":"Vandanmagsar B, Youm Y-H, Ravussin A, Galgani JE, Stadler K, Mynatt RL, Ravussin E, Stephens JM, Dixit VD (2011) The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med 17:179\u2013188","journal-title":"Nat Med"},{"key":"3817_CR113","doi-asserted-by":"publisher","first-page":"570711","DOI":"10.3389\/fneur.2020.570711","volume":"11","author":"KL Hanslik","year":"2020","unstructured":"Hanslik KL, Ulland TK (2020) The role of microglia and the Nlrp3 inflammasome in Alzheimer\u2019s disease. Front Neurol 11:570711","journal-title":"Front Neurol"},{"key":"3817_CR114","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ni.1636","volume":"9","author":"A Halle","year":"2008","unstructured":"Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, Reinheckel T, Fitzgerald KA, Latz E, Moore KJ, Golenbock DT (2008) The NALP3 inflammasome is involved in the innate immune response to amyloid-\u03b2. Nat Immunol 9:857\u2013865","journal-title":"Nat Immunol"},{"key":"3817_CR115","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","volume":"575","author":"C Ising","year":"2019","unstructured":"Ising C, Venegas C, Zhang S, Scheiblich H, Schmidt SV, Vieira-Saecker A, Schwartz S, Albasset S, McManus RM, Tejera D (2019) NLRP3 inflammasome activation drives tau pathology. Nature 575:669\u2013673","journal-title":"Nature"},{"key":"3817_CR116","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1038\/sj.ijo.0802501","volume":"27","author":"S Shoelson","year":"2003","unstructured":"Shoelson S, Lee J, Yuan M (2003) Inflammation and the IKK\u03b2\/I\u03baB\/NF-\u03baB axis in obesity-and diet-induced insulin resistance. Int J Obes 27:S49\u2013S52","journal-title":"Int J Obes"},{"key":"3817_CR117","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3233\/JAD-2009-0976","volume":"16","author":"I Granic","year":"2009","unstructured":"Granic I, Dolga AM, Nijholt IM, van Dijk G, Eisel UL (2009) Inflammation and NF-kappaB in Alzheimer\u2019s disease and diabetes. J Alzheimers Dis 16:809\u2013821","journal-title":"J Alzheimers Dis"},{"key":"3817_CR118","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fcvm.2020.00037","volume":"7","author":"L Ega\u00f1a-Gorro\u00f1o","year":"2020","unstructured":"Ega\u00f1a-Gorro\u00f1o L, L\u00f3pez-D\u00edez R, Yepuri G, Ramirez LS, Reverdatto S, Gugger PF, Shekhtman A, Ramasamy R, Schmidt AM (2020) Receptor for advanced glycation end products (RAGE) and mechanisms and therapeutic opportunities in diabetes and cardiovascular disease: insights from human subjects and animal models. Front Cardiovasc Med 7:37","journal-title":"Front Cardiovasc Med"},{"key":"3817_CR119","doi-asserted-by":"publisher","first-page":"576","DOI":"10.4158\/1934-2403-26.5.576","volume":"26","author":"MS Beeri","year":"2020","unstructured":"Beeri MS, Uribarri J, Cai W, Buchman AS, Haroutunian V (2020) Human Brain and serum advanced glycation end products are highly correlated: preliminary results of their role in Alzheimer disease and type 2 diabetes. Endocr Pract 26:576\u2013577","journal-title":"Endocr Pract"},{"key":"3817_CR120","doi-asserted-by":"publisher","first-page":"813","DOI":"10.3389\/fnins.2018.00813","volume":"12","author":"JM Gaspar","year":"2018","unstructured":"Gaspar JM, Velloso LA (2018) Hypoxia inducible factor as a central regulator of metabolism\u2014\u00a0implications for the development of obesity. Front Neurosci 12:813","journal-title":"Front Neurosci"},{"key":"3817_CR121","doi-asserted-by":"publisher","first-page":"310","DOI":"10.4103\/1673-5374.290898","volume":"16","author":"H Hassan","year":"2021","unstructured":"Hassan H, Chen R (2021) Hypoxia in Alzheimer\u2019s disease: effects of hypoxia inducible factors. Neural Regener Res 16:310\u2013311","journal-title":"Neural Regener Res"},{"key":"3817_CR122","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3389\/fnins.2018.00314","volume":"12","author":"F Zhang","year":"2018","unstructured":"Zhang F, Zhong R, Qi H, Li S, Cheng C, Liu X, Liu Y, Le W (2018) Impacts of acute hypoxia on Alzheimer\u2019s disease-like pathologies in APPswe\/PS1dE9 mice and their wild type littermates. Front Neurosci 12:314","journal-title":"Front Neurosci"},{"key":"3817_CR123","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.2147\/NDT.S203103","volume":"15","author":"R Lall","year":"2019","unstructured":"Lall R, Mohammed R, Ojha U (2019) What are the links between hypoxia and Alzheimer\u2019s disease? Neuropsychiatr Dis Treat 15:1343","journal-title":"Neuropsychiatr Dis Treat"},{"key":"3817_CR124","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.3390\/nu12113506","volume":"12","author":"S Mariani","year":"2020","unstructured":"Mariani S, Di Giorgio MR, Rossi E, Tozzi R, Contini S, Bauleo L, Cipriani F, Toscano R, Basciani S, Barbaro G (2020) Blood SIRT1 shows a coherent association with leptin and adiponectin in relation to the degree and distribution of adiposity: a study in obesity, normal weight and anorexia nervosa. Nutrients 12:3506","journal-title":"Nutrients"},{"key":"3817_CR125","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/cns.13216","volume":"26","author":"H Kuang","year":"2020","unstructured":"Kuang H, Tan CY, Tian HZ, Liu LH, Yang MW, Hong FF, Yang SL (2020) Exploring the bi-directional relationship between autophagy and Alzheimer\u2019s disease. CNS Neurosci Ther 26:155\u2013166","journal-title":"CNS Neurosci Ther"},{"key":"3817_CR126","doi-asserted-by":"publisher","first-page":"921","DOI":"10.3390\/biom12070921","volume":"12","author":"C Sousa","year":"2022","unstructured":"Sousa C, Mendes AF (2022) Monoterpenes as sirtuin-1 activators: therapeutic potential in aging and related diseases. Biomolecules 12:921","journal-title":"Biomolecules"},{"key":"3817_CR127","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s40263-017-0431-2","volume":"31","author":"L Li","year":"2017","unstructured":"Li L (2017) The molecular mechanism of glucagon-like peptide-1 therapy in Alzheimer\u2019s disease, based on a mechanistic target of rapamycin pathway. CNS Drugs 31:535\u2013549","journal-title":"CNS Drugs"},{"key":"3817_CR128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.metabol.2017.06.002","volume":"74","author":"J Rheinheimer","year":"2017","unstructured":"Rheinheimer J, de Souza BM, Cardoso NS, Bauer AC, Crispim D (2017) Current role of the NLRP3 inflammasome on obesity and insulin resistance: a systematic review. Metabolism 74:1\u20139","journal-title":"Metabolism"},{"key":"3817_CR129","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.bcp.2014.08.013","volume":"92","author":"S Legrand-Poels","year":"2014","unstructured":"Legrand-Poels S, Esser N, L\u2019homme L, Scheen A, Paquot N, Piette J (2014) Free fatty acids as modulators of the NLRP3 inflammasome in obesity\/type 2 diabetes. Biochem Pharmacol 92:131\u2013141","journal-title":"Biochem Pharmacol"},{"key":"3817_CR130","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s12035-013-8475-x","volume":"48","author":"M-S Tan","year":"2013","unstructured":"Tan M-S, Yu J-T, Jiang T, Zhu X-C, Tan L (2013) The NLRP3 inflammasome in Alzheimer\u2019s disease. Mol Neurobiol 48:875\u2013882","journal-title":"Mol Neurobiol"},{"key":"3817_CR131","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00401-018-01957-y","volume":"137","author":"I-C Stancu","year":"2019","unstructured":"Stancu I-C, Cremers N, Vanrusselt H, Couturier J, Vanoosthuyse A, Kessels S, Lodder C, Br\u00f4ne B, Huaux F, Octave J-N (2019) Aggregated Tau activates NLRP3\u2013ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo. Acta Neuropathol 137:599\u2013617","journal-title":"Acta Neuropathol"},{"key":"3817_CR132","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/s41583-018-0055-7","volume":"19","author":"MT Heneka","year":"2018","unstructured":"Heneka MT, McManus RM, Latz E (2018) Inflammasome signalling in brain function and neurodegenerative disease. Nat Rev Neurosci 19:610\u2013621","journal-title":"Nat Rev Neurosci"},{"key":"3817_CR133","first-page":"1","volume":"Rev","author":"HM Al-Kuraishy","year":"2022","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Al-Maiahy TJ, Alexiou A, Mukerjee N, Batiha GE-S (2022) Prostaglandins and non-steroidal anti-inflammatory drugs in Covid-19. Biotechnol Genet Eng Rev:1\u201321","journal-title":"Biotechnol Genet Eng"},{"key":"3817_CR134","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.tcb.2012.08.001","volume":"22","author":"L Tornatore","year":"2012","unstructured":"Tornatore L, Thotakura AK, Bennett J, Moretti M, Franzoso G (2012) The nuclear factor kappa B signaling pathway: integrating metabolism with inflammation. Trends Cell Biol 22:557\u2013566","journal-title":"Trends Cell Biol"},{"key":"3817_CR135","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.lfs.2018.02.039","volume":"198","author":"YP Guo","year":"2018","unstructured":"Guo YP, Jiang HK, Jiang H, Tian HY, Li L (2018) Lipoxin A4 may attenuate the progression of obesity-related glomerulopathy by inhibiting NF-\u03baB and ERK\/p38 MAPK-dependent inflammation. Life Sci 198:112\u2013118","journal-title":"Life Sci"},{"key":"3817_CR136","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-022-01070-3","author":"GE-S Batiha","year":"2022","unstructured":"Batiha GE-S, Al-Gareeb AI, Elekhnawy E, Al-Kuraishy HM (2022) Potential role of lipoxin in the management of COVID-19: a narrative review. Inflammopharmacology. https:\/\/doi.org\/10.1007\/s10787-022-01070-3","journal-title":"Inflammopharmacology"},{"key":"3817_CR137","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1038\/s41467-019-09588-x","volume":"10","author":"J Ben","year":"2019","unstructured":"Ben J, Jiang B, Wang D, Liu Q, Zhang Y, Qi Y, Tong X, Chen L, Liu X, Zhang Y, Zhu X, Li X, Zhang H, Bai H, Yang Q, Ma J, Wiemer EAC, Xu Y, Chen Q (2019) Major vault protein suppresses obesity and atherosclerosis through inhibiting IKK-NF-\u03baB signaling mediated inflammation. Nat Commun 10:1801","journal-title":"Nat Commun"},{"key":"3817_CR138","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jns.2016.05.022","volume":"366","author":"ZM Shi","year":"2016","unstructured":"Shi ZM, Han YW, Han XH, Zhang K, Chang YN, Hu ZM, Qi HX, Ting C, Zhen Z, Hong W (2016) Upstream regulators and downstream effectors of NF-\u03baB in Alzheimer\u2019s disease. J Neurol Sci 366:127\u2013134","journal-title":"J Neurol Sci"},{"key":"3817_CR139","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/alzrt150","volume":"4","author":"WJ Lukiw","year":"2012","unstructured":"Lukiw WJ (2012) NF-\u03baB-regulated, proinflammatory miRNAs in Alzheimer\u2019s disease. Alzheimers Res Ther 4:47","journal-title":"Alzheimers Res Ther"},{"key":"3817_CR140","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/0006-8993(96)00310-1","volume":"735","author":"K Terai","year":"1996","unstructured":"Terai K, Matsuo A, McGeer PL (1996) Enhancement of immunoreactivity for NF-kappa B in the hippocampal formation and cerebral cortex of Alzheimer\u2019s disease. Brain Res 735:159\u2013168","journal-title":"Brain Res"},{"key":"3817_CR141","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/1871527316666170807130011","volume":"18","author":"C Ju Hwang","year":"2019","unstructured":"Ju Hwang C, Choi DY, Park MH, Hong JT (2019) NF-\u03baB as a key mediator of brain inflammation in Alzheimer\u2019s disease. CNS Neurol Disord Drug Targets 18:3\u201310","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"3817_CR142","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.3390\/biomedicines10082032","volume":"10","author":"AW Al-Thomali","year":"2022","unstructured":"Al-Thomali AW, Al-Kuraishy HM, Al-Gareeb AI, De AKA-BM, Sabatier JM, Khan Khalil AA, Saad HM, Batiha GE (2022) Role of neuropilin 1 in COVID-19 patients with acute ischemic stroke. Biomedicines 10:2032","journal-title":"Biomedicines"},{"key":"3817_CR143","doi-asserted-by":"publisher","first-page":"402","DOI":"10.2174\/1381612826666201118092422","volume":"27","author":"MS Uddin","year":"2021","unstructured":"Uddin MS, Hasana S, Ahmad J, Hossain MF, Rahman MM, Behl T, Rauf A, Ahmad A, Hafeez A, Perveen A, Ashraf GM (2021) Anti-neuroinflammatory potential of polyphenols by inhibiting NF-\u03baB to halt Alzheimer\u2019s disease. Curr Pharm Des 27:402\u2013414","journal-title":"Curr Pharm Des"},{"key":"3817_CR144","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.phrs.2017.11.030","volume":"129","author":"EJ Seo","year":"2018","unstructured":"Seo EJ, Fischer N, Efferth T (2018) Phytochemicals as inhibitors of NF-\u03baB for treatment of Alzheimer\u2019s disease. Pharmacol Res 129:262\u2013273","journal-title":"Pharmacol Res"},{"key":"3817_CR145","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s12974-020-01967-2","volume":"17","author":"F Kong","year":"2020","unstructured":"Kong F, Jiang X, Wang R, Zhai S, Zhang Y, Wang D (2020) Forsythoside B attenuates memory impairment and neuroinflammation via inhibition on NF-\u03baB signaling in Alzheimer\u2019s disease. J Neuroinflamm 17:305","journal-title":"J Neuroinflamm"},{"key":"3817_CR146","doi-asserted-by":"publisher","first-page":"649128","DOI":"10.3389\/fnut.2021.649128","volume":"8","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Faidah H, Al-Maiahy TJ, Cruz-Martins N, Batiha GE (2021) The looming effects of estrogen in Covid-19: a rocky rollout. Front Nutr 8:649128","journal-title":"Front Nutr"},{"key":"3817_CR147","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1210\/js.2019-00160","volume":"3","author":"K Asadipooya","year":"2019","unstructured":"Asadipooya K, Uy EM (2019) Advanced glycation end products (AGEs), receptor for AGEs, diabetes, and bone: review of the literature. J Endocr Soc 3:1799\u20131818","journal-title":"J Endocr Soc"},{"key":"3817_CR148","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.metabol.2014.07.017","volume":"64","author":"MA Tsoukas","year":"2015","unstructured":"Tsoukas MA, Farr OM, Mantzoros CS (2015) Leptin in congenital and HIV-associated lipodystrophy. Metabolism 64:47\u201359","journal-title":"Metabolism"},{"key":"3817_CR149","doi-asserted-by":"publisher","first-page":"7867852","DOI":"10.1155\/2016\/7867852","volume":"2016","author":"WN Sayej","year":"2016","unstructured":"Sayej WN, Knight Iii PR, Guo WA, Mullan B, Ohtake PJ, Davidson BA, Khan A, Baker RD, Baker SS (2016) Advanced glycation end products induce obesity and hepatosteatosis in CD-1 wild-type mice. Biomed Res Int 2016:7867852","journal-title":"Biomed Res Int"},{"key":"3817_CR150","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4161\/derm.17999","volume":"4","author":"C den Engelsen","year":"2012","unstructured":"den Engelsen C, van den Donk M, Gorter KJ, Salom\u00e9 PL, Rutten GE (2012) Advanced glycation end products measured by skin autofluorescence in a population with central obesity. Dermatoendocrinol 4:33\u201338","journal-title":"Dermatoendocrinol"},{"key":"3817_CR151","doi-asserted-by":"publisher","first-page":"22194","DOI":"10.1038\/s41598-020-79216-y","volume":"10","author":"MH Sohouli","year":"2020","unstructured":"Sohouli MH, Sharifi-Zahabi E, Lari A, Fatahi S, Shidfar F (2020) The impact of low advanced glycation end products diet on obesity and related hormones: a systematic review and meta-analysis. Sci Rep 10:22194","journal-title":"Sci Rep"},{"key":"3817_CR152","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1021\/acschemneuro.8b00442","volume":"10","author":"F Zhang","year":"2019","unstructured":"Zhang F, Niu L, Li S, Le W (2019) Pathological impacts of chronic hypoxia on Alzheimer\u2019s disease. ACS Chem Neurosci 10:902\u2013909","journal-title":"ACS Chem Neurosci"},{"key":"3817_CR153","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41573-020-0072-x","volume":"19","author":"SC Cunnane","year":"2020","unstructured":"Cunnane SC, Trushina E, Morland C, Prigione A, Casadesus G, Andrews ZB, Beal MF, Bergersen LH, Brinton RD, de la Monte S, Eckert A, Harvey J, Jeggo R, Jhamandas JH, Kann O, la Cour CM, Martin WF, Mithieux G, Moreira PI, Murphy MP, Nave KA, Nuriel T, Oliet SHR, Saudou F, Mattson MP, Swerdlow RH, Millan MJ (2020) Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing. Nat Rev Drug Discov 19:609\u2013633","journal-title":"Nat Rev Drug Discov"},{"key":"3817_CR154","first-page":"680","volume":"86","author":"E Babusikova","year":"2021","unstructured":"Babusikova E, Dobrota D, Turner AJ, Nalivaeva NN (2021) Effect of global brain ischemia on amyloid precursor protein metabolism and expression of amyloid-degrading enzymes in rat cortex: role in pathogenesis of Alzheimer\u2019s disease. Biochemistry 86:680\u2013692","journal-title":"Biochemistry"},{"key":"3817_CR155","doi-asserted-by":"publisher","first-page":"7189","DOI":"10.1021\/acs.jmedchem.1c00415","volume":"64","author":"Y Wu","year":"2021","unstructured":"Wu Y, Li Z, McDonough MA, Schofield CJ, Zhang X (2021) Inhibition of the oxygen-sensing asparaginyl hydroxylase factor inhibiting hypoxia-inducible factor: a potential hypoxia response modulating strategy. J Med Chem 64:7189\u20137209","journal-title":"J Med Chem"},{"key":"3817_CR156","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.bbi.2018.06.020","volume":"73","author":"JM Gaspar","year":"2018","unstructured":"Gaspar JM, Mendes NF, Corr\u00eaa-da-Silva F, Lima-Junior JC, Gaspar RC, Ropelle ER, Araujo EP, Carvalho HM, Velloso LA (2018) Downregulation of HIF complex in the hypothalamus exacerbates diet-induced obesity. Brain Behav Immun 73:550\u2013561","journal-title":"Brain Behav Immun"},{"key":"3817_CR157","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/1440-1681.12717","volume":"44","author":"BS Ashok","year":"2017","unstructured":"Ashok BS, Ajith TA, Sivanesan S (2017) Hypoxia-inducible factors as neuroprotective agent in Alzheimer\u2019s disease. Clin Exp Pharmacol Physiol 44:327\u2013334","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"3817_CR158","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.2147\/NDT.S203103","volume":"15","author":"R Lall","year":"2019","unstructured":"Lall R, Mohammed R, Ojha U (2019) What are the links between hypoxia and Alzheimer\u2019s disease? Neuropsychiatr Dis Treat 15:1343\u20131354","journal-title":"Neuropsychiatr Dis Treat"},{"key":"3817_CR159","first-page":"1027","volume":"45","author":"J Li","year":"2020","unstructured":"Li J, Tao T, Xu J, Liu Z, Zou Z, Jin M (2020) HIF\u20131\u03b1 attenuates neuronal apoptosis by upregulating EPO expression following cerebral ischemia\u2013reperfusion injury in a rat MCAO model. Int J Mol Med 45:1027\u20131036","journal-title":"Int J Mol Med"},{"key":"3817_CR160","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4236\/aar.2016.51002","volume":"5","author":"IJ Martins","year":"2016","unstructured":"Martins IJ (2016) Anti-aging genes improve appetite regulation and reverse cell senescence and apoptosis in global populations. Adv Aging Res 5:9\u201326. https:\/\/doi.org\/10.4236\/aar.2016.51002","journal-title":"Adv Aging Res"},{"key":"3817_CR161","doi-asserted-by":"publisher","first-page":"24","DOI":"10.21767\/2472-1158.100058","volume":"3","author":"IJ Martins","year":"2017","unstructured":"Martins IJ (2017) Single gene inactivation with implications to diabetes and multiple organ dysfunction syndrome. J Clin Epigenet 3:24. https:\/\/doi.org\/10.21767\/2472-1158.100058","journal-title":"J Clin Epigenet"},{"key":"3817_CR162","unstructured":"Martins I (2019) Appetite regulation and the peripheral sink amyloid beta clearance pathway in diabetes and Alzheimer\u2019s disease. In: Top 10 commentaries in Alzheimer\u2019s disease. Avid Sci, pp\u00a02\u201311"},{"key":"3817_CR163","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.diabres.2013.07.002","volume":"101","author":"YS Song","year":"2013","unstructured":"Song YS, Lee SK, Jang YJ, Park HS, Kim J-H, Lee YJ, Heo Y-S (2013) Association between low SIRT1 expression in visceral and subcutaneous adipose tissues and metabolic abnormalities in women with obesity and type 2 diabetes. Diabetes Res Clin Pract 101:341\u2013348","journal-title":"Diabetes Res Clin Pract"},{"key":"3817_CR164","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3389\/fendo.2015.00109","volume":"6","author":"T Sasaki","year":"2015","unstructured":"Sasaki T (2015) Age-associated weight gain, leptin, and SIRT1: a possible role for hypothalamic SIRT1 in the prevention of weight gain and aging through modulation of leptin sensitivity. Front Endocrinol 6:109","journal-title":"Front Endocrinol"},{"key":"3817_CR165","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2174\/1567202616666181128120003","volume":"15","author":"K Maiese","year":"2018","unstructured":"Maiese K (2018) Sirtuins: developing innovative treatments for aged-related memory loss and Alzheimer\u2019s disease. Curr Neurovasc Res 15:367\u2013371","journal-title":"Curr Neurovasc Res"},{"key":"3817_CR166","doi-asserted-by":"publisher","first-page":"001","DOI":"10.4172\/1747-0862.S1-001","volume":"S1","author":"IJ Martins","year":"2013","unstructured":"Martins IJ (2013) Increased risk for obesity and diabetes with neurodegeneration in developing countries. J Mol Genet Med S1:001. https:\/\/doi.org\/10.4172\/1747-0862.S1-001","journal-title":"J Mol Genet Med"},{"key":"3817_CR167","doi-asserted-by":"publisher","first-page":"8152373","DOI":"10.1155\/2018\/8152373","volume":"2018","author":"BAQ Gomes","year":"2018","unstructured":"Gomes BAQ, Silva JPB, Romeiro CFR, Dos Santos SM, Rodrigues CA, Gon\u00e7alves PR, Sakai JT, Mendes PFS, Varela ELP, Monteiro MC (2018) Neuroprotective mechanisms of resveratrol in Alzheimer\u2019s disease: role of SIRT1. Oxid Med Cell Longev 2018:8152373. https:\/\/doi.org\/10.1155\/2018\/8152373","journal-title":"Oxid Med Cell Longev"},{"key":"3817_CR168","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.phrs.2018.11.041","volume":"139","author":"W San Cheang","year":"2019","unstructured":"San Cheang W, Wong WT, Wang L, Cheng CK, Lau CW, Ma RCW, Xu A, Wang N, Huang Y, Tian XY (2019) Resveratrol ameliorates endothelial dysfunction in diabetic and obese mice through sirtuin 1 and peroxisome proliferator-activated receptor \u03b4. Pharmacol Res 139:384\u2013394","journal-title":"Pharmacol Res"},{"key":"3817_CR169","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/jnc.12380","volume":"128","author":"DJ Bonda","year":"2014","unstructured":"Bonda DJ, Stone JG, Torres SL, Siedlak SL, Perry G, Kryscio R, Jicha G, Casadesus G, Smith MA, Zhu X (2014) Dysregulation of leptin signaling in Alzheimer disease: evidence for neuronal leptin resistance. J Neurochem 128:162\u2013172","journal-title":"J Neurochem"},{"key":"3817_CR170","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1001\/jama.2009.1836","volume":"302","author":"W Lieb","year":"2009","unstructured":"Lieb W, Beiser AS, Vasan RS, Tan ZS, Au R, Harris TB, Roubenoff R, Auerbach S, DeCarli C, Wolf PA (2009) Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. JAMA 302:2565\u20132572","journal-title":"JAMA"},{"key":"3817_CR171","doi-asserted-by":"publisher","first-page":"e3098","DOI":"10.1371\/journal.pone.0003098","volume":"3","author":"GJ Paz-Filho","year":"2008","unstructured":"Paz-Filho GJ, Babikian T, Asarnow R, Esposito K, Erol HK, Wong M-L, Licinio J (2008) Leptin replacement improves cognitive development. PLoS ONE 3:e3098","journal-title":"PLoS ONE"},{"key":"3817_CR172","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.bbrc.2009.01.041","volume":"380","author":"SJ Greco","year":"2009","unstructured":"Greco SJ, Sarkar S, Johnston JM, Tezapsidis N (2009) Leptin regulates tau phosphorylation and amyloid through AMPK in neuronal cells. Biochem Biophys Res Commun 380:98\u2013104","journal-title":"Biochem Biophys Res Commun"},{"key":"3817_CR173","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.3233\/JAD-2010-1298","volume":"19","author":"G Marwarha","year":"2010","unstructured":"Marwarha G, Dasari B, Prasanthi JR, Schommer J, Ghribi O (2010) Leptin reduces the accumulation of A\u03b2 and phosphorylated tau induced by 27-hydroxycholesterol in rabbit organotypic slices. J Alzheimers Dis 19:1007\u20131019","journal-title":"J Alzheimers Dis"},{"key":"3817_CR174","doi-asserted-by":"publisher","first-page":"105219","DOI":"10.1016\/j.nbd.2020.105219","volume":"148","author":"ML Cali\u00f3","year":"2021","unstructured":"Cali\u00f3 ML, Mosini AC, Marinho DS, Salles GN, Massinhani FH, Ko GM, Porcionatto MA (2021) Leptin enhances adult neurogenesis and reduces pathological features in a transgenic mouse model of Alzheimer\u2019s disease. Neurobiol Dis 148:105219","journal-title":"Neurobiol Dis"},{"key":"3817_CR175","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s11011-018-0203-9","volume":"33","author":"A King","year":"2018","unstructured":"King A, Brain A, Hanson K, Dittmann J, Vickers J, Fernandez-Martos C (2018) Disruption of leptin signalling in a mouse model of Alzheimer\u2019s disease. Metab Brain Dis 33:1097\u20131110","journal-title":"Metab Brain Dis"},{"key":"3817_CR176","doi-asserted-by":"publisher","first-page":"6964","DOI":"10.3390\/molecules27206964","volume":"27","author":"S Shafiq","year":"2022","unstructured":"Shafiq S, Zahan R, Yesmin S, Khan A, Mahmud MS, Reza MA, Albogami SM, Alorabi M, De Waard M, Saad HM, Sabatier J-M, Naz T, Batiha GE-S (2022) Phytochemical analysis and understanding the antioxidant and anticancer properties of methanol extract from Litsea glutinosa: in vitro and in vivo studies. Molecules 27:6964","journal-title":"Molecules"},{"key":"3817_CR177","doi-asserted-by":"publisher","first-page":"592","DOI":"10.3390\/ijms18030592","volume":"18","author":"RC-L Ng","year":"2017","unstructured":"Ng RC-L, Chan K-H (2017) Potential neuroprotective effects of adiponectin in Alzheimer\u2019s disease. Int J Mol Sci 18:592","journal-title":"Int J Mol Sci"},{"key":"3817_CR178","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12017-012-8201-2","volume":"15","author":"AL Teixeira","year":"2013","unstructured":"Teixeira AL, Diniz BS, Campos AC, Miranda AS, Rocha NP, Talib LL, Gattaz WF, Forlenza OV (2013) Decreased levels of circulating adiponectin in mild cognitive impairment and Alzheimer\u2019s disease. Neuromol Med 15:115\u2013121","journal-title":"Neuromol Med"},{"key":"3817_CR179","doi-asserted-by":"publisher","first-page":"e52354","DOI":"10.1371\/journal.pone.0052354","volume":"7","author":"K-H Chan","year":"2012","unstructured":"Chan K-H, Lam KS-L, Cheng O-Y, Kwan JS-C, Ho PW-L, Cheng KK-Y, Chung SK, Ho JW-M, Guo VY, Xu A (2012) Adiponectin is protective against oxidative stress induced cytotoxicity in amyloid-beta neurotoxicity. PLoS ONE 7:e52354","journal-title":"PLoS ONE"},{"key":"3817_CR180","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.nutres.2018.12.007","volume":"63","author":"E Nova","year":"2019","unstructured":"Nova E, San Mauro-Mart\u00edn I, D\u00edaz-Prieto LE, Marcos A (2019) Wine and beer within a moderate alcohol intake is associated with higher levels of HDL-c and adiponectin. Nutr Res 63:42\u201350","journal-title":"Nutr Res"},{"key":"3817_CR181","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/jdi.12579","volume":"8","author":"HV Tong","year":"2017","unstructured":"Tong HV, Luu NK, Son HA, Hoan NV, Hung TT, Velavan TP, Toan NL (2017) Adiponectin and pro-inflammatory cytokines are modulated in Vietnamese patients with type 2 diabetes mellitus. J Diabetes Investig 8:295\u2013305","journal-title":"J Diabetes Investig"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-022-03817-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-022-03817-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-022-03817-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:54:58Z","timestamp":1728435298000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-022-03817-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,21]]},"references-count":181,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["3817"],"URL":"https:\/\/doi.org\/10.1007\/s11064-022-03817-4","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,21]]},"assertion":[{"value":"27 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}